Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

Clinical trial NCT02298647 · WITHDRAWN

Trial details

NCT number: NCT02298647
Sponsor: CENTOGENE GmbH Rostock
Status: WITHDRAWN
Study type: OBSERVATIONAL

Hepato-splenomegaly Dysostosis Multiplex Seizures Mental Retardation

Start date: 2018-08-20
Primary completion: 2021-02-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.